Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles
The application of nanomedicines is increasing rapidly with the promise of targeted and
efficient drug delivery. Nanomedicines address the shortcomings of conventional therapy, as …
efficient drug delivery. Nanomedicines address the shortcomings of conventional therapy, as …
The formulation of nanomedicines for treating tuberculosis
A Costa, M Pinheiro, J Magalhães, R Ribeiro… - Advanced drug delivery …, 2016 - Elsevier
Recent estimates indicate that tuberculosis (TB) is the leading cause of death worldwide,
alongside the human immunodeficiency virus (HIV) infection. The current treatment is …
alongside the human immunodeficiency virus (HIV) infection. The current treatment is …
Nanostructured drug delivery for better management of tuberculosis
With almost 30% of the world population suffering from tuberculosis (TB) including its
resurgence in the developed world, better management of this global threat is highly …
resurgence in the developed world, better management of this global threat is highly …
Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis
Tuberculosis (TB) has gone from being a forgotten disease to a modern and recrudescent
pathology from past decades. Some clinical problems and challenges associated with …
pathology from past decades. Some clinical problems and challenges associated with …
Niosomal encapsulation of the antitubercular drug, pyrazinamide
MS El-Ridy, A Abdelbary, EA Nasr… - Drug development …, 2011 - Taylor & Francis
It is estimated that more than one-third of the world population is infected with
Mycobacterium tuberculosis. Pyrazinamide (PZA) plays a unique role in shortening therapy …
Mycobacterium tuberculosis. Pyrazinamide (PZA) plays a unique role in shortening therapy …
Molecular encapsulation of rifampicin as an inclusion complex of hydroxypropyl-β-cyclodextrin: Design; characterization and in vitro dissolution
D He, P Deng, L Yang, Q Tan, J Liu, M Yang… - Colloids and surfaces B …, 2013 - Elsevier
A hydrophobic drug, rifampin (RFP), was molecularly encapsulated into hydroxylpropyl-β-
cyclodextrin (HCD) to form a molecular inclusion complex (MRICD) with higher solubility and …
cyclodextrin (HCD) to form a molecular inclusion complex (MRICD) with higher solubility and …
Folic acid-conjugated cellulose nanocrystals show high folate-receptor binding affinity and uptake by KB and breast cancer cells
The study evaluates cellulose nanocrystals (CNCs) as nanocarriers for targeted, intracellular
delivery of molecular agents. CNCs were labeled with fluorescein-5′-isothiocyanate as an …
delivery of molecular agents. CNCs were labeled with fluorescein-5′-isothiocyanate as an …
Drug delivery for tuberculosis: is inhaled therapy the key to success?
Worldwide, tuberculosis (TB) has 86% treatment success rate in new cases, leaving more
than 1 million new patients without a cure [1]. Thus, the need for both shorter treatment …
than 1 million new patients without a cure [1]. Thus, the need for both shorter treatment …
[PDF][PDF] 脂质体制备技术及其研究进展
刘晓谦， 王锦玉， 仝燕， 王智民 - 中国药学杂志, 2011 - journal11.magtechjournal.com
目的综述脂质体制备技术的研究进展及其发展前景. 方法以近年来的研究文献为基础,
结合药物的性质, 工艺要求, 对脂质体的制备方法进行综述, 并对各种方法的优缺点进行分析 …
结合药物的性质, 工艺要求, 对脂质体的制备方法进行综述, 并对各种方法的优缺点进行分析 …
Simultaneous liposomal encapsulation of antibiotics and proteins: Co-loading and characterization of rifampicin and Human Serum Albumin in soy-liposomes
The recurrent development of resistance to antimicrobial agents threatens the ability for
successful treatment of infectious diseases. Hydrophobic antibiotics such as rifampicin (Rif) …
successful treatment of infectious diseases. Hydrophobic antibiotics such as rifampicin (Rif) …